CEO Post: Pfizer Vet Leads 1 New Phase 3 Biotech Firm
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
phase 3 trial
Read More
Pfizer vet to lead 1 new phase 3-ready biotech as CEO
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
3 wins for Regeneron: Phase 3 trial success vs allergies
Regeneron’s itepekimab antibody treatment posts 3 wins in Phase 3 trials, showing significant improvement against both cat allergies and seasonal pollen allergies.
Gout Drug from Atom Shows Phase 3 Win Over Rivals
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.